FLT1 and neoplasm: On the other hand, it can cut off the tumor cell nutrition supply and inhibit tumor growth through the inhibition of vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), platelet-derived growth factor receptor (PDGFR-β) and the formation of tumor angiogenesis [46].